Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
Clinical trial NCT05153239 · COMPLETED
Trial details
- NCT number
- NCT05153239
- Sponsor
- PharmaMar
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2026-04-10
- Enrollment
- 705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.